(Q35945671)

11 August 2017

title

Mode of death from congestive heart failure: implications for clinical management (English)

1 reference

11 August 2017

main subject

congestive heart failure

1 reference

Mary Clare Derfler

1

1 reference

11 August 2017

Mark Jacob

2

1 reference

11 August 2017

Robert E Wolf

3

1 reference

11 August 2017

Frank Bleyer

4

1 reference

11 August 2017

Paul J Hauptman

5

1 reference

11 August 2017

language of work or name

1 reference

1 November 2004

1 reference

The American Journal of Geriatric Cardiology

11 August 2017

published in

1 reference

11 August 2017

volume

13

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

299-304; quiz 305-6

1 reference

Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Congestive heart failure in the community: trends in incidence and survival in a 10-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Representation of the elderly, women, and minorities in heart failure clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Consensus statement: Palliative and supportive care in advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Mode of death in chronic heart failure. A request and proposition for more accurate classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Physiological substrate for antidromic reciprocating tachycardia. Prerequisite characteristics of the accessory pathway and atrioventricular conduction system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Mode of death in heart failure: findings from the ATLAS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

The prognostic importance of different definitions of worsening renal function in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Survival of Medicare patients after enrollment in hospice programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Dobutamine for Patients with End-Stage Heart Failure in a Hospice Program?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

Lifetime Risk for Developing Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2004.03476.X

10.1111/J.1076-7460.2004.03476.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference